Skip to main content

Bringing Canadian innovations to our healthcare system and the world.

Learn more about the EAHN™ program

OBIO’s Early Adopter Health Network (EAHN™)

EAHN™ matches Canadian health technology companies with a national network of healthcare organizations to evaluate technologies in the real-world setting and to facilitate their broad adoption into the health system.

Proudly supporting partnerships between Canadian health technology companies and health system.

OBIO®, through EAHN™, supports health technology companies and healthcare organizations to evaluate technologies in the real-world setting, widely disseminate technologies that prove value-producing, and create showcase sites to demonstrate successful Canadian technologies to the global market. Financial support is available for both the company and healthcare organization during the evaluation.

Companies

Canada is home to some of the world’s most innovative companies with a strong history of developing state of the art healthcare solutions.

Healthcare Organizations

The EAHN™ program facilitates industry-driven partnerships with healthcare organizations that help Canada’s health system improve patient care, provider satisfaction and system efficiency.

Ecosystem Partners

EAHN™ works with national and regional innovation partners in the health sciences ecosystem to assist companies and health partners with resources, adoption strategies and program support.

“

UHN is pleased to be part of the OBIO® EAHN™ program and support the early adoption of innovative technologies that improve patient lives and clinical efficiency. The products evaluated through this program help to demonstrate UHN’s interest in advancing leading-edge Canadian technologies.

Mark Taylor, Director Technology Development and CommercializationUniversity Health Network
“

Working together with Ontario’s leading health organizations through the OBIO® EAHN™ program provides companies like Synaptive Medical with a base of Canadian customers and experiences that strengthen our global value proposition.

Cameron Piron, PresidentSynaptive
“

Southlake Regional Health Centre has a long history of engaging with innovators. The OBIO® EAHN™ program has allowed us to ‘up our game’ with access to pre-vetted, commercial ready Canadian technologies – letting us focus on completing the type of value-based analysis that supports future procurement. We see this approach as the kind of win-win that benefits patients both here and around the world.

Rob Bull, VP Finance and InnovationSouthlake Regional Health Centre
“

Leveraging the positive results from the OBIO® EAHN™ evaluation allows us to make final technology enhancements in our home market – where our R&D and manufacturing facility reside. Having local customers who become adoption champions is key to successfully accessing the global marketplace.

Patrick Myles, CEOHuron Digital
“

Our participation in the EAHN™ was a catalyzing event for our recent financing round, and I wanted to say thank you for putting this important program in place.

Joe Eibl, CEOFlosonics Medical

For any additional questions, please contact us.

Get in touch

Contact us

OBIO®
108 College St., Suite W1020, Toronto, Ontario M5G 0C6

(416) 848 6839
info@obio.ca